Clinical trial · Observational
HPV and Male Homosexuality in General Practice?
HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Papilloma Viral Infection | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?
- timeFrame
- Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 26 Years
Show eligibility criteria text
Inclusion criteria: * Age: 18-26 years * Consultation at the HUS Cegidd as part of an STI screening * Subject who expressed no opposition to participating in the study Exclusion criteria: * Refusal of the patient to participate in the study * Subject who had already benefited from HPV vaccination (at least one dose) * Inability to give informed consent * Subject under safeguarde of justice * Subject under guardianship or under curatorship
References
Publications (0)
Data not yet available